000 01136 a2200301 4500
005 20250515071921.0
264 0 _c20071017
008 200710s 0 0 eng d
022 _a1347-9032
024 7 _a10.1111/j.1349-7006.2007.00529.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTakeda, Kazuyoshi
245 0 0 _aCombination antibody-based cancer immunotherapy.
_h[electronic resource]
260 _bCancer science
_cSep 2007
300 _a1297-302 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aAntibodies, Monoclonal
_xadverse effects
650 0 4 _aAntibodies, Neoplasm
_xadverse effects
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadverse effects
650 0 4 _aDrug Delivery Systems
_xadverse effects
650 0 4 _aHumans
650 0 4 _aImmunotherapy, Active
_xadverse effects
700 1 _aOkumura, Ko
700 1 _aSmyth, Mark J
773 0 _tCancer science
_gvol. 98
_gno. 9
_gp. 1297-302
856 4 0 _uhttps://doi.org/10.1111/j.1349-7006.2007.00529.x
_zAvailable from publisher's website
999 _c17097997
_d17097997